UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032799
Receipt number R000037379
Scientific Title Multicenter prospective observational study to examine the predictability of pathological assessment for staging of cardiomyopathy
Date of disclosure of the study information 2018/06/01
Last modified on 2022/06/03 13:18:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter prospective observational study to examine the predictability of pathological assessment for staging of cardiomyopathy

Acronym

Multicenter prospective observational study with pathological assessment in cardiomyopathy

Scientific Title

Multicenter prospective observational study to examine the predictability of pathological assessment for staging of cardiomyopathy

Scientific Title:Acronym

Multicenter prospective observational study with pathological assessment in cardiomyopathy

Region

Japan


Condition

Condition

cardiomyopathy

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine a pathological assessment with electron microscopy for predicting cardiac prognosis, including reverse remodeling, in multicenter prospective observational study and to investigate for the establishment of blood markers related to cardiac prognosis and pathological changes

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cardiac event (cardiac death or LVAD implantation)

Key secondary outcomes

Reverse remodeling, change of LVEF, change of LV dimension


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients (LVEF<40%) who consent to participation and have a scheduled myocardial biopsy within 1 month

2. Patients without coronary artery disease or valvular disease as a major cause of cardiac dysfunction

Key exclusion criteria

1. Patients with systemic disease with poor prognosis (within 1 year)
2. Patients with LVAD support
3. no follow-up
4. Patients without standard treatment
5. Patients judged to be inappropriate by investigator

Target sample size

180


Research contact person

Name of lead principal investigator

1st name Yasushi
Middle name
Last name Sakata

Organization

Osaka University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code

565-0871

Address

2-2 Yamadaoka, Suita, Osaka, 565-0871 Japan

TEL

06-6879-3631

Email

yasushisk@cardiology.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Tomohito
Middle name
Last name Ohtani

Organization

Osaka University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code

565-0871

Address

2-2 Yamadaoka, Suita, Osaka, 565-0871 Japan

TEL

06-6879-3638

Homepage URL


Email

ohtani@cardiology.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Clinical Research Review Committee

Address

Yamadaoka 2-15, Suita City, Osaka

Tel

06-6210-8296

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部附属病院(大阪府)、国立循環器病研究センター(大阪府)、東京大学医学部附属病院(東京都)、名古屋大学医学部附属病院(愛知県)、大阪急性期・総合医療センター(大阪府)


Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 05 Month 27 Day

Date of IRB

2018 Year 05 Month 28 Day

Anticipated trial start date

2018 Year 06 Month 01 Day

Last follow-up date

2021 Year 06 Month 30 Day

Date of closure to data entry

2021 Year 09 Month 28 Day

Date trial data considered complete

2021 Year 10 Month 01 Day

Date analysis concluded



Other

Other related information

This study is a prospective observational study.
Data for analysis is as follows:
*Pathological findings (electron microscopic assessments)
*Cardiac events
*Echocardiographic data
*Patients characteristics, including laboratory data


Management information

Registered date

2018 Year 05 Month 31 Day

Last modified on

2022 Year 06 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037379


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name